SCOPUS 정보 검색 플랫폼

Acta Neurologica Scandinavica

Volumn 105, Issue 1, 2002, Pages 8-12

Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users

(5) Van De Vijver, D A M C a Roos, R A C b Jansen, P A F c Porsius, A J a De Boer, A a

a UTRECHT UNIVERSITY (Netherlands)

b LEIDEN UNIVERSITY MEDICAL CENTER (Netherlands)

c UNIVERSITY MEDICAL CENTER UTRECHT (Netherlands)

Author keywords

Antiparkinsonian drug treatment; Benzodiazepine; Levodopa; Parkinson's disease; Pharmacoepidemiology

Indexed keywords

AMANTADINE; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; FLURAZEPAM; LEVODOPA; LORMETAZEPAM; NITRAZEPAM; OXAZEPAM; SELEGILINE; TEMAZEPAM;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; BASAL GANGLIA; BENZODIAZEPINES; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0036186187 PISSN: 00016314 EISSN: None Source Type: Journal
DOI: 10.1034/j.1600-0404.2002.00132.x Document Type: Article

Times cited : (10)

References (29)

1
- 0032941795
- Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA (A) receptors in vivo
- (1999) Neuroscience , vol.89 , pp. 799-812
- Paladini, C.A.¹ Celada, P.² Tepper, J.M.³

2
- 0029071232
- Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: Involvement of a GABAergic mechanism
- (1995) J Pharmacol Exp Ther , vol.274 , pp. 84-89
- Tenn, C.C.¹ Niles, L.P.²

3
- 0029093690
- Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat
- (1995) Eur J Pharmacol , vol.284 , pp. 83-91
- Smolders, I.¹ De Klippel, N.² Sarre, S.³ Ebinger, G.⁴ Michotte, Y.⁵

4
- 0000965479
- Hypnotics and sedatives; ethanol
- Hardman J, Limbird L, Molinoff P, Ruddon R, Goodman Gilman A, eds. New York: McGraw-Hill
- (1996) Goodman and Gilman's the pharmacological basis of therapeutics , pp. 361-396
- Hobbs, W.T.¹ Rall, T.² Verdoorn, T.³

5
- 23544475523
- Increased use of psychotropic drugs by patients with Parkinson's disease
- (1999) Br J Clin Pharmacol , vol.47 , pp. 476P
- Van de Vijver, D.A.M.C.¹ De Boer, A.² Herings, R.M.C.³ Roos, R.A.C.⁴ Porsius, A.J.⁵

6
- 0031933258
- An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines
- (1998) Am Acad Neurol Neurol , vol.50 , pp. S1-S57
- Olanow, C.W.¹ Koller, W.C.²

7
- 0032837272
- Range of neuropsychiatric disturbances in patients with Parkinson's disease
- (1999) J Neurol Neurosurg Psychiatry , vol.67 , pp. 492-496
- Aarsland, D.¹ Larsen, J.P.² Lim, N.G.³

8
- 0024309705
- Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease
- (1989) Mov Disord , vol.4 , pp. 195-201
- Pourcher, E.¹ Bonnet, A.M.² Kefalos, J.³ Dubois, B.⁴ Agid, Y.⁵

9
- 0014955421
- Use of levodopa with other drugs
- (1970) Lancet , vol.2 , pp. 1283-1285
- Hunter, K.R.¹ Stern, G.M.² Laurence, D.R.³

10
- 0020056123
- Chlordiazepoxide interaction with levodopa
- (1982) Ann Intern Med , vol.96 , pp. 259-260
- Yosselson-Superstine, S.¹ Lipman, A.G.²

11
- 0026049514
- A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients
- (1991) Age Ageing , vol.20 , pp. 424-429
- Tulloch, J.A.¹ Ashwood, T.J.² Bateman, D.N.³ Woodhouse, K.W.⁴

12
- 0023216250
- Adjuvant therapy of parkinsonian tremor
- (1987) Arch Neurol , vol.44 , pp. 921-923
- Koller, W.C.¹ Herbster, G.²

13
- 4243497165
- Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa
- (2000) Pharmacoepidemiol Drug Saf , vol.9 , pp. S11-S12
- Van de Vijver, D.A.M.C.¹ Roos, R.A.C.² Jansen, P.A.F.³ Porsius, A.J.⁴ De Boer, A.⁵

14
- 0026578226
- Pharmaco-morbidity linkage: A feasibility study comparing morbidity in two pharmacy based exposure cohorts
- (1992) J Epidemiol Community Health , vol.46 , pp. 136-140
- Herings, R.M.¹ Bakker, A.² Stricker, B.H.³ Nap, G.⁴

15
- 0034842876
- Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease
- (2001) Pharm World Sci , vol.23 , pp. 148-152
- Van de Vijver, D.A.M.C.¹ Stricker, B.H.C.² Breteler, M.M.B.³ Roos, R.A.C.⁴ Porsius, A.J.⁵ De Boer, A.⁶

16
- 0029435462
- Prevalence of Parkinson's disease in the elderly: The Rotterdam study
- (1995) Neurology , vol.45 , pp. 2143-2146
- De Rijk, M.C.¹ Breteler, M.M.B.² Graveland, G.A.³

17
- 0024468807
- Metoclopramide-induced movement disorders. Clinical findings with a review of the literature
- (1989) Arch Intern Med , vol.149 , pp. 2486-2492
- Miller, L.G.¹ Jankovic, J.²

18
- 0031025533
- A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism
- (1997) Mov Disord , vol.12 , pp. 107-110
- Negrotti, A.¹ Calzetti, S.²

19
- 0002172544
- Drugs effective in the therapy of the epilepsies
- Hardman J, Limbird L, Molinoff P, Ruddon R, Goodman Gilman A, eds. New York: McGraw-Hill
- (1996) Goodman and Gilman's the pharmacological basis of therapeutics , pp. 461-486
- McNamara, J.¹

20
- 0020110694
- Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint
- (1982) Biometrics , vol.38 , pp. 163-170
- Schoenfeld, D.A.¹ Richter, J.R.²

21
- 0003435337
- New York: John Wiley
- (1999) Applied survival analysis. Regression modeling of time to event data , pp. 386
- Hosmer, D.¹ Lemeshow, S.²

22
- 0026514953
- Accuracy of diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases
- (1992) J Neurol Neurosurg Psychiatry , vol.55 , pp. 181-184
- Hughes, A.J.¹ Daniel, S.E.² Kilford, L.³ Lees, A.J.⁴

23
- 0032799828
- Sleep benefit in Parkinson's disease
- (1999) J Neurol Neurosurg Psychiatry , vol.67 , pp. 384-385
- Bateman, D.E.¹ Levett, K.² Marsden, C.D.³

24
- 0030818267
- Sleep benefit in Parkinson's disease
- (1997) Mov Disord , vol.12 , pp. 506-508
- Merello, M.¹ Hughes, A.² Colosimo, C.³ Hoffman, M.⁴ Starkstein, S.⁵ Leiguarda, R.⁶

25
- 0032722316
- Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based study
- (1999) Mov Disord , vol.14 , pp. 922-927
- Tandberg, E.¹ Larsen, J.P.² Karlsen, K.³

26
- 0027398680
- Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis
- (1993) Br J Anaesth , vol.70 , pp. 181-185
- Takada, K.¹ Murai, T.² Kanayama, T.³ Koshikawa, N.⁴

27
- 0343090499
- Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease
- (2000) Mov Disord , vol.15 , pp. 734-735
- Ruzicka, E.¹ Roth, J.² Jech, R.³ Busek, P.⁴

28
- 0030936557
- Zolpidem in Parkinson's disease
- (1997) Lancet , vol.349 , pp. 1222-1223
- Daniele, A.¹ Albanese, A.² Gainotti, G.³ Gregori, B.⁴ Bartolomeo, P.⁵

29
- 0029082271
- Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life
- (1995) Arch Intern Med , vol.155 , pp. 1801-1807
- Herings, R.M.¹ Stricker, B.H.² De Boer, A.³ Bakker, A.⁴ Sturmans, F.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.